Brookline Capital Markets

Brookline Capital Markets specializes in providing capital markets and strategic advisory services to public and private life sciences, medical technology, and diagnostics companies. It has acted as bookrunner, co-manager, lead/co-placement agent or advisor on over 200 transactions since 2017 for healthcare clients at all stages of development. The firm also offers equity research coverage for more than 40 life sciences companies through its in-house analysts and a partnership with Edison Investment Research. It has raised over $400 million across more than 30 private capital market transactions as exclusive/lead/co-placement agent. Its client base includes emerging growth enterprises in the healthcare sector as well as SPACs. No clinical results or pipeline programs are associated with the firm itself. Brookline does not develop therapeutics; it provides investment banking and advisory services to companies that do.